Department of Medicine Archive — Page 112 of 127

Close-up of multiple clear blood collection tubes with blue caps arranged diagonally on a white background; the tubes contain red liquid.
September 3, 2015

Bad “traffic” linked to cancer

Understanding how signaling molecules are transported within and out of the cell may help to uncover the causes of certain cancers.

Three-dimensional molecular model showing clustered green spheres surrounded by several red spheres on a white background.
August 20, 2015

New therapeutic target for diabetes

The factor FoxM1 increases the proliferation and function of insulin-producing beta cells, making it an attractive therapeutic target for diabetes.

Portrait of W. Kimryn Rathmell wearing glasses, a white blazer, and a navy floral blouse.
August 13, 2015

Rathmell to direct Division of Hematology and Oncology

W. Kimryn Rathmell, M.D., Ph.D., Alexander Professor for Translational Science and associate director for Training and Education at Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, has been named director of Vanderbilt’s Division of Hematology and Oncology.

Portrait of Russell Rothman, M.D., wearing glasses, a suit, and tie.
August 13, 2015

Grant bolsters Clinical Data Research Network

The Mid-South Clinical Data Research Network, led by Vanderbilt University’s Russell Rothman, M.D., M.P.P., has been approved for a three-year, $8.5 million funding award from the independent Patient-Centered Outcomes Research Institute (PCORI) to expand its efforts to improve healthcare throughout the Southeast.

kidney x-ray
August 13, 2015

Million Veteran Program data spurs research in pharmacogenomics of kidney disease

A team of Vanderbilt and Nashville VA researchers, led by Adriana Hung, M.D., MPH, has been awarded a grant from the U.S. Department of Veterans Affairs to use the Million Veteran Program (MVP) data to conduct diabetes research.

genetic sequence
August 6, 2015

Genotyping project to be an ‘engine of discovery’

Vanderbilt University researchers next month will launch a major initiative to acquire “dense genotypes” from 100,000 individuals whose medical histories are known.